Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00017914 · ClinicalTrials.gov registry record

Adult and Juvenile Myositis

A clinical trial of Dermatomyositis and Inclusion Body Myositis, sponsored by National Institute of Environmental Health Sciences (NIEHS).

Recruiting
Registry status
1,200
Enrollment target
4
Study locations

NCT00017914: Recruiting study of Dermatomyositis and Inclusion Body Myositis, sponsored by National Institute of Environmental Health Sciences (NIEHS).

NCT00017914 is a study of Dermatomyositis and Inclusion Body Myositis that is actively recruiting participants, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 1,200 participants, above the 422-participant average among 19 other Dermatomyositis trials with a reported enrollment target (184% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00017914, a study of Dermatomyositis and Inclusion Body Myositis, is actively recruiting participants, sponsored by National Institute of Environmental Health Sciences (NIEHS).

RECRUITING
Registry status
1,200 participants
Enrollment target
4
Study locations

Study Summary

This study will evaluate subjects with adult- and childhood-onset myositis to learn more about their cause and the immune system changes and medical problems associated with them. Myositis is an inflammatory muscle disease that can damage muscles and other organs, resulting in significant disability. Children or adults with polymyositis or dermatomyositis or a related condition may be evaluated under this study. Healthy children or adults will also be enrolled as "controls," for comparison of test results. All patients will undergo a complete history (including completing some questionnaires) and physical examination, review of medical records, and blood and urine tests. Patients may then choose to participate in an additional 1- to 5-day evaluation, which will include some or all of the following diagnostic, treatment or research procedures: 1. Standardized muscle strength testing, range of motion of joints and walking (gait) analysis by a physiotherapist; completion of a questionnaire regarding ability to perform daily tasks 2. Skin assessment, possibly including photographs of lesions and a skin biopsy (removal of a small skin sample under local anesthetic) 3. Magnetic resonance imaging (scans that use magnetic fields to visualize tissues) of leg muscles 4. Swallowing studies, including a physical examination and questionnaire on swallowing ability, studies of tongue strength, and ultrasound imaging during swallowing, and possibly, a modified barium swallow 5. Voice and speech assessment, possibly including computerized voice analysis and laryngoscopy-analysis of the larynx (voice box) using a small rigid scope with a camera placed in the mouth to view and record vocal cord function 6. Pulmonary function tests (measurement of air moved into and out of the lungs, using a breathing machine) to evaluate lung function and, possibly, chest X-ray 7. Electrocardiogram (measurement of the electrical activity of the heart) and, possibly, echocardiogram (ultrasound imag

Primary Outcome

1- A secure internet accessible IMACS Outcomes Data Repository of core set disease activity, damage and quality of life measures has been established for adult and juvenile myositis patients as part of IMACS. 2- Compare the clinical and immunopathogenic features of childhood and adult IIM to determine the differences of IIM in these two populations referred to NIH 3- investigate the immunopathogenesis and immunogenetics of IIM.

Study Locations (4)

Georgia

  • Emory University - Atlanta

Maryland

  • National Institutes of Health Clinical Center - Bethesda

North Carolina

  • NIEHS Clinical Research Unit (CRU) - Research Triangle Park

Texas

  • Texas Scottish Rite Hospital - Dallas

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 1995-06-07

What NCT00017914 shows while recruiting

NCT00017914 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, above the 422-participant average among 19 other Dermatomyositis trials with a reported enrollment target (184% higher).

The record links to 3 conditions, with Dermatomyositis appearing as the primary indexed condition, and to 0 interventions.

NCT00017914 reports a single indexed study location in Georgia, Maryland, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00017914 about?

NCT00017914 is a clinical study titled "Adult and Juvenile Myositis". This study will evaluate subjects with adult- and childhood-onset myositis to learn more about their cause and the immune system changes and medical problems associated with them. Myositis is an inflammatory muscle disease that can damage muscles and other organs, resulting in significant disability...

What is the current status of trial NCT00017914?

This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 1995-06-07.

What conditions does trial NCT00017914 study?

This clinical trial studies the following conditions: Dermatomyositis, Inclusion Body Myositis, Polymyositis.

Who is sponsoring clinical trial NCT00017914?

This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00017914 being conducted?

This trial has 4 study locations across Georgia, Maryland, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dermatomyositis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00017914's enrollment target sits among peer trials

1,200 2nd of 19 the highest of 19 other Dermatomyositis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dermatomyositis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001987 · 1,200 participants

    Genetic Studies of Insulin and Diabetes

  • NCT00477100 · 1,200 participants

    Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

  • NCT01209000 · 1,200 participants

    Nephrotic Syndrome Study Network

  • NCT01944332 · 1,200 participants · NA

    Gamete Treatment to Correct Fertilization Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00017914, the US trial registry maintained by the National Library of Medicine. NCT00017914 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.